Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New revision tag v3.5.5 was added to the page history and the v3.5.4 entry was removed. This is an administrative metadata update and does not modify study details.
    Difference
    0.0%
    Check dated 2026-06-07T00:22:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, indicating a new build of the site. This update appears to be a backend or packaging change with no visible edits to study information or the page’s user-facing content.
    Difference
    0.0%
    Check dated 2026-05-16T09:47:52.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Taoyuan City, Taiwan has been added to the list of study locations, and Taoyuan, Taiwan has been removed. This change refines the location entry to reflect the correct municipal designation for the site.
    Difference
    0.0%
    Check dated 2026-05-02T04:36:37.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version has been updated from v3.5.2 to v3.5.3, indicating a website release/version change rather than an update to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T22:27:56.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T14:09:17.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    No substantive changes to the page content were detected. The study overview, design, eligibility criteria, and outcomes remain as shown.
    Difference
    0.0%
    Check dated 2026-04-10T09:10:56.000Z thumbnail image

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.